Topics

AstraZeneca FY19 Core Operating Profit Rises; Sales Up 12%

02:46 EST 14 Feb 2020 | FinanzNachrichten

LONDON (dpa-AFX) - AstraZeneca plc (AZN.L, AZN) reported profit before tax of $1.55 billion for the year ended 31 December 2019 compared to $1.99 billion, previous year. Earnings per $0.25 ordinar...

Original Article: AstraZeneca FY19 Core Operating Profit Rises; Sales Up 12%

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca FY19 Core Operating Profit Rises; Sales Up 12%"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...